{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-026104","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.853044+00:00","generated_at":"2026-05-31T10:03:44.190545+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Pulse Biosciences posts updated investor presentation on website; no new financial data disclosed","bullets":["Updated deck highlights progress on CellFX nsPFA 360 Cardiac Catheter, Cardiac Surgery System, and Percutaneous Electrode.","Investor presentation is dated August 2024 and available on company's website.","No specific milestones, clinical data, or financial guidance included in filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-026104","json":"https://secwatch.observer/filing/0001437749-24-026104.json","markdown":"https://secwatch.observer/filing/0001437749-24-026104.md","text":"https://secwatch.observer/filing/0001437749-24-026104.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774924026104/0001437749-24-026104-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774924026104/plse20240812_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:03:44.190545+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}